Koziel Katarzyna,

University / Clinic: DSL Daniel Swarovski Research Laboratory
Institute: Department of General and Transplant Surgery
 
Research Area: Cytoplasmic signal transduction

Email: katarzyna.koziel@i-med.ac.at
Web: http://www.i-med.ac.at/tx-research/


Research Topic:
Controlling life/death decisions through crosstalk between cytoplasmic signaling and mitochondria

Selected publications:
 
  Ashraf M, Ebner M, Wallner C, Haller M, Khalid S, Schwelberger H, Koziel K, Enthammer M, Hermann M, Sickinger S, Soleiman A, Steger C, Vallant S, Sucher R, Brandacher G, Santer P, Dragun D, Troppmair
A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.
Cell Commun Signal. 2014 Jan 14;12:6

  Enthammer M, Papadakis E, Salomé Gachet M, Deutsch M, Schwaiger S, Koziel K, Ashraf M, Khalid S, Wolber G, Packham G, Cutress R, Stuppner H, Troppmair J
Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines.
Mol Cancer Ther. 2013 Nov;12(11):2400-14. doi: 10.1158/1535-7163.MCT-13-0142. Epub 2013 Sep 18. PubM

  Koziel K, Smigelskaite J, Drasche A, Enthammer M, Ashraf M, Khalid S, Troppmair J

RAF and antioxidants prevent cell death induction after growth factor abrogation through regulation of Bcl-2 proteins.
Exp Cell Res. 2013 Oct 15;319(17):2728-38. doi: 10.1016/j.yexcr.2013.07.029. Epub 2013 Aug 7. PubMed